Studies have found 21-day treatment with low dose (20 IU) or high dose (40 IU) of long-lasting insulin detemir in 60 adults with MCI or AD resulted in improved memory, but only in the high-dose group [168]. This evidence concerns the gene INS and Alzheimer disease.